WO2003041645A3 - Methode de vaccination d'un patient humain pour prevenir les tumeurs metastatiques - Google Patents
Methode de vaccination d'un patient humain pour prevenir les tumeurs metastatiques Download PDFInfo
- Publication number
- WO2003041645A3 WO2003041645A3 PCT/US2002/035957 US0235957W WO03041645A3 WO 2003041645 A3 WO2003041645 A3 WO 2003041645A3 US 0235957 W US0235957 W US 0235957W WO 03041645 A3 WO03041645 A3 WO 03041645A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- tumors
- human patient
- vaccinating
- methods
- metastatic tumors
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/282—Platinum compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/243—Platinum; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Abstract
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP02778802A EP1453468A4 (fr) | 2001-11-09 | 2002-11-08 | Methode de vaccination d'un patient humain pour prevenir les tumeurs metastatiques |
AU2002340439A AU2002340439A1 (en) | 2001-11-09 | 2002-11-08 | Method of vaccinating a human patient to prevent metastatic tumors |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US33798401P | 2001-11-09 | 2001-11-09 | |
US60/337,984 | 2001-11-09 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2003041645A2 WO2003041645A2 (fr) | 2003-05-22 |
WO2003041645A3 true WO2003041645A3 (fr) | 2003-07-24 |
Family
ID=23322894
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2002/035957 WO2003041645A2 (fr) | 2001-11-09 | 2002-11-08 | Methode de vaccination d'un patient humain pour prevenir les tumeurs metastatiques |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP1453468A4 (fr) |
AU (1) | AU2002340439A1 (fr) |
WO (1) | WO2003041645A2 (fr) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2571696B (en) | 2017-10-09 | 2020-05-27 | Compass Pathways Ltd | Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced |
AU2020257625A1 (en) | 2019-04-17 | 2021-11-04 | Compass Pathfinder Limited | Methods for treating anxiety disorders, headache disorders, and eating disorders with psilocybin |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0739210B1 (fr) * | 1993-12-29 | 2002-07-24 | Matrix Pharmaceutical, Inc. | Compositions pour l'administration locale d'agents antitumoraux |
US5478556A (en) * | 1994-02-28 | 1995-12-26 | Elliott; Robert L. | Vaccination of cancer patients using tumor-associated antigens mixed with interleukin-2 and granulocyte-macrophage colony stimulating factor |
-
2002
- 2002-11-08 AU AU2002340439A patent/AU2002340439A1/en not_active Abandoned
- 2002-11-08 EP EP02778802A patent/EP1453468A4/fr not_active Withdrawn
- 2002-11-08 WO PCT/US2002/035957 patent/WO2003041645A2/fr not_active Application Discontinuation
Non-Patent Citations (3)
Title |
---|
GRIMM E.A. ET AL.: "Unexprected cytokines in serum of malignant melanoma patients during sequential biochemotherapy", CLIN. CANCER RES., vol. 6, no. 10, October 2000 (2000-10-01), pages 3895 - 3903, XP002963858 * |
MUGINOVA S.: "Inhibition of peroxidase, trypsin and alpha-chymotrypsin by platinum(II) and platinum(IV) complexes", BIOCHEMISTRY (MOSC), vol. 64, no. 4, April 1999 (1999-04-01), pages 399 - 404 * |
PAVIA M.B.: "Laser and cisplatinum for treatment of human squamous cell carcinoma", LARYNGOSCOPE, vol. 108, no. 9, September 1998 (1998-09-01), pages 1269 - 1276 * |
Also Published As
Publication number | Publication date |
---|---|
WO2003041645A2 (fr) | 2003-05-22 |
EP1453468A4 (fr) | 2005-11-23 |
EP1453468A2 (fr) | 2004-09-08 |
AU2002340439A1 (en) | 2003-05-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2005062972A3 (fr) | Traitement du cancer au moyen de nouveaux anticorps monoclonaux anti-il 13 | |
EP2022800A3 (fr) | Compositions utilisés dans la thérapie et le diagnostic du cancer des ovaires | |
WO2000036107A3 (fr) | Compositions et procedes destines a la therapie et au diagnostic du cancer de l"ovaire | |
HUP0300421A2 (hu) | Kezelési eljárás ligand-immunogén konjugátumok felhasználásával | |
EP2116262A3 (fr) | Analyse de détection génique permettant d'améliorer la probabilité d'une réponse efficace à une thérapie du cancer basée sur un antagoniste d'ErbB | |
WO2000062800A3 (fr) | Vaccins | |
WO2003030934A3 (fr) | Formulations cpg et procedes y relatifs | |
TR199802676A3 (tr) | Tümörlerin, tümörle ilgili hastaliklarin ve kaseksinin tedavisi ve önlenmesi için yöntem. | |
TR200103560T2 (tr) | Göğüs kanserinin teşhis ve tedavisi için bileşimler ve bunların kullanımı | |
AU2003267203A8 (en) | Method for administering thermotherapy to prevent the growth of tumors | |
CA2396865A1 (fr) | Inhibiteurs de la farnesyl proteine transferase pour le traitement du cancer du sein | |
DK1165537T3 (da) | Hydroxymatairesinol til forebyggelse af cancer | |
IL201889A (en) | Medication for the treatment of vaccine-related disorders containing antibodies that specifically recognize the nk 1.1 antigen or cd56 antigen expressed by nk t cells | |
WO1998045328A3 (fr) | Compositions therapeutiques et diagnostiques du carcinome mammaire et methodes afferentes | |
ATE485833T1 (de) | Pharmazeutische zusammensetzungen, die die immunogenität von schwach immunogenen antigenen fördern | |
WO2002078516A3 (fr) | Compositions et methodes de traitement et de diagnostic de cancers | |
WO2005007673A3 (fr) | Peptides immunogenes | |
WO2001018046A3 (fr) | Sequences de tumeurs ovariennes et procedes d'utilisation correspondants | |
WO2000061756A3 (fr) | Composes pour l'immunotherapie et le diagnostic du cancer du sein et procedes d'utilisation | |
WO2001014395A3 (fr) | Nouveaux glycoconjuges et acides glycoamino leurs intermediaires et leurs utilisations | |
EE05241B1 (et) | Distamtsiini a-halogenoakrlolderivaadi kasutamine | |
WO2003041645A3 (fr) | Methode de vaccination d'un patient humain pour prevenir les tumeurs metastatiques | |
WO2001090152A3 (fr) | Compositions et procedes pour la therapie et le diagnostic du cancer du sein | |
WO2003093298A3 (fr) | Peptides immunogenes | |
WO2000052045A3 (fr) | Peptides immunogenes derives de mage-3 presentes par le complexe majeur d'histocompatibilte (mch) de categorie ii et utilisations associees |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SC SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2002778802 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2002778802 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2002778802 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |